BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28979205)

  • 1. Atrophy of the Posterior Subiculum Is Associated with Memory Impairment, Tau- and Aβ Pathology in Non-demented Individuals.
    Lindberg O; Mårtensson G; Stomrud E; Palmqvist S; Wahlund LO; Westman E; Hansson O
    Front Aging Neurosci; 2017; 9():306. PubMed ID: 28979205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Hippocampal Subfield Volume Reduction and Plasma Biomarker Changes in Mild Cognitive Impairment and Alzheimer's Disease.
    Cao J; Tang Y; Chen S; Yu S; Wan K; Yin W; Zhen W; Zhao W; Zhou X; Zhu X; Sun Z
    J Alzheimers Dis; 2024; 98(3):907-923. PubMed ID: 38489180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.
    Almdahl IS; Lauridsen C; Selnes P; Kalheim LF; Coello C; Gajdzik B; Møller I; Wettergreen M; Grambaite R; Bjørnerud A; Bråthen G; Sando SB; White LR; Fladby T
    Front Aging Neurosci; 2017; 9():9. PubMed ID: 28223932
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of Hippocampal Subfields, CSF Biomarkers, and Cognition in Patients With Parkinson Disease Without Dementia.
    Becker S; Granert O; Timmers M; Pilotto A; Van Nueten L; Roeben B; Salvadore G; Galpern WR; Streffer J; Scheffler K; Maetzler W; Berg D; Liepelt-Scarfone I
    Neurology; 2021 Feb; 96(6):e904-e915. PubMed ID: 33219138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.
    Müller-Ehrenberg L; Riphagen JM; Verhey FRJ; Sack AT; Jacobs HIL;
    J Alzheimers Dis; 2018; 66(2):811-823. PubMed ID: 30320590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex and Education Modify the Association Between Subjective Cognitive Decline and Amyloid Pathology.
    Bolton CJ; Khan OA; Liu D; Wilhoite S; Dumitrescu L; Peterson A; Blennow K; Zetterberg H; Hohman TJ; Jefferson AL; Gifford KA
    medRxiv; 2023 Nov; ():. PubMed ID: 37961115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction.
    Düzel E; Ziegler G; Berron D; Maass A; Schütze H; Cardenas-Blanco A; Glanz W; Metzger C; Dobisch L; Reuter M; Spottke A; Brosseron F; Fliessbach K; Heneka MT; Laske C; Peters O; Priller J; Spruth EJ; Ramirez A; Speck O; Schneider A; Teipel S; Kilimann I; Jens W; Schott BH; Preis L; Gref D; Maier F; Munk MH; Roy N; Ballarini T; Yakupov R; Haynes JD; Dechent P; Scheffler K; Wagner M; Jessen F
    Brain; 2022 May; 145(4):1473-1485. PubMed ID: 35352105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatially distinct atrophy is linked to β-amyloid and tau in preclinical Alzheimer disease.
    Wang L; Benzinger TL; Hassenstab J; Blazey T; Owen C; Liu J; Fagan AM; Morris JC; Ances BM
    Neurology; 2015 Mar; 84(12):1254-60. PubMed ID: 25716355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.
    Rosenberg A; Solomon A; Jelic V; Hagman G; Bogdanovic N; Kivipelto M
    Alzheimers Res Ther; 2019 Dec; 11(1):99. PubMed ID: 31805990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glial activation and inflammation along the Alzheimer's disease continuum.
    Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
    J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson's disease.
    Low A; Foo H; Yong TT; Tan LCS; Kandiah N
    J Neurol Neurosurg Psychiatry; 2019 Jun; 90(6):681-687. PubMed ID: 30683708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of abnormal Alzheimer's disease biomarkers in patients with subjective cognitive decline: cross-sectional comparison of three European memory clinic samples.
    Wolfsgruber S; Molinuevo JL; Wagner M; Teunissen CE; Rami L; Coll-Padrós N; Bouwman FH; Slot RER; Wesselman LMP; Peters O; Luther K; Buerger K; Priller J; Laske C; Teipel S; Spottke A; Heneka MT; Düzel E; Drzezga A; Wiltfang J; Sikkes SAM; van der Flier WM; Jessen F;
    Alzheimers Res Ther; 2019 Jan; 11(1):8. PubMed ID: 30654834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study.
    Alves G; Brønnick K; Aarsland D; Blennow K; Zetterberg H; Ballard C; Kurz MW; Andreasson U; Tysnes OB; Larsen JP; Mulugeta E
    J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1080-6. PubMed ID: 20547614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential associations of visual memory with hippocampal subfields in subjective cognitive decline and amnestic mild cognitive impairment.
    Huang Y; Huang L; Wang Y; Liu Y; Lo CZ; Guo Q
    BMC Geriatr; 2022 Feb; 22(1):153. PubMed ID: 35209845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease.
    Gomar JJ; Conejero-Goldberg C; Davies P; Goldberg TE;
    J Alzheimers Dis; 2016; 51(4):1085-97. PubMed ID: 26967213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts.
    Haas AL; Olm P; Utz J; Siegmann EM; Spitzer P; Florvaag A; Schmidt MA; Doerfler A; Lewczuk P; Kornhuber J; Maler JM; Oberstein TJ;
    Front Aging Neurosci; 2023; 15():1121500. PubMed ID: 36909947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline.
    Perrotin A; de Flores R; Lamberton F; Poisnel G; La Joie R; de la Sayette V; Mézenge F; Tomadesso C; Landeau B; Desgranges B; Chételat G
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S141-50. PubMed ID: 26402076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.